Selective beta2-receptor agonists for the treatment of asthma—therapeutic breakthrough or advertising ploy?
- 1 December 1976
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 89 (6) , 1020-1026
- https://doi.org/10.1016/s0022-3476(76)80625-7
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Long-Term Metaproterenol Therapy in Asthmatic ChildrenPublished by American Medical Association (AMA) ,1976
- Double-Blind Comparison of Acute Bronchial and Cardiovascular Effects of Oral Terbutaline and EphedrineChest, 1975
- Dosage of Theophylline in Bronchial AsthmaNew England Journal of Medicine, 1975
- Evaluation of a New Oral β2-Adrenoceptor Stimulant Bronchodilator, TerbutalinePharmacology, 1975
- Bronchodilator effects of terbutaline and epinephrine in obstructive lung diseaseClinical Pharmacology & Therapeutics, 1974
- Terbutaline in children with asthmaArchives of Disease in Childhood, 1973
- Oral preparations of isoetharine compared with orciprenaline and choline theophyllinateRespiratory Medicine, 1971
- Differentiation of Receptor Systems activated by Sympathomimetic AminesNature, 1967
- METAFROTERENOL, A NEW BRONCHODILATORThe Lancet Healthy Longevity, 1967